Search clinical trials for: Cdc7-inhibitor (BMS-863233)
Total 1687 results
-
Bristol-Myers SquibbTerminatedHIV-1 InfectionThailand, United States, Australia, Canada, Spain, Colombia, South Africa, Hungary, France, Peru, Argentina, Chile, Mexico
-
Bristol-Myers SquibbCompletedChronic Hepatitis CFrance, United States, Puerto Rico
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBRCA1 Gene Mutation | BRCA2 Gene Mutation | Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7 | BRIP1 Gene Mutation | PALB2 Gene Mutation | ATM Gene Mutation | ATR Gene Mutation | CHEK2 Gene Mutation | NBN Gene Mutation | RAD51 Gene Mutation | CHEK1 Gene Mutation | FANCA Gene... and other conditionsUnited States, Canada
-
Bristol-Myers SquibbCompletedSystemic Lupus Erythematosus | Healthy ParticipantsUnited States
-
ViiV HealthcareGlaxoSmithKlineCompletedInfection, Human Immunodeficiency VirusUnited States
-
ViiV HealthcareGlaxoSmithKlineCompleted
-
ViiV HealthcareActive, not recruitingHIV InfectionsUnited States, Spain, France, Australia, Germany, Belgium, Canada, Argentina, Brazil, Italy, Romania, Mexico, Taiwan, Netherlands, South Africa, Russian Federation, Greece, Portugal, United Kingdom, Poland, Peru, Chile, Colombia, Ireland and more
-
Mark SteinBristol-Myers Squibb; ExelixisRecruitingCYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition (Cyto-KIK)Kidney Cancer | Renal Cell CarcinomaUnited States
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid TumorCanada, United States, Mexico
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid CancersUnited States, Canada
-
AstraZenecaAstra Zeneca, Bristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States
-
Bristol-Myers SquibbCompletedUrothelial CarcinomaUnited States
-
Bristol-Myers SquibbCompletedUnresectable Stage III or IV Malignant MelanomaUnited States, Peru, Norway, Italy, Sweden, Denmark, Israel
-
Bristol-Myers SquibbCompletedProstate CancerUnited States, France, Mexico, Sweden, Canada, Australia, Italy, Colombia, Denmark, Argentina, Chile, Spain, Germany, Puerto Rico, United Kingdom, Czech Republic, Romania, Norway, Poland, Netherlands, Brazil, Hungary, Turkey, Greece
-
Bristol-Myers SquibbCompletedMelanomaSouth Africa, United States, Spain, France, Italy, Belgium, Austria, Israel, Germany, Norway, Canada, Brazil, Poland, Denmark, Czech Republic, Russian Federation, Ukraine, Argentina
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingNon Small Cell Lung CancerUnited States, China, Hungary, Brazil, Argentina, Canada, France, Greece, Italy, Japan, Korea, Republic of, Romania, Spain, Taiwan, Turkey
-
Bristol-Myers SquibbNektar TherapeuticsTerminatedEwing Sarcoma | Ependymoma | Medulloblastoma | Neuroblastoma | Rhabdomyosarcoma | High-grade Glioma | Leukemia and Lymphoma | Miscellaneous Brain Tumors | Miscellaneous Solid Tumors | Relapsed, Refractory Malignant NeoplasmsUnited States, Australia, France, Germany, Italy, Spain
-
M.D. Anderson Cancer CenterJanssen Scientific Affairs, LLCWithdrawnLung Cancer, Nonsmall Cell, Stage I
-
Bristol-Myers SquibbMedarexCompletedMelanomaFrance, United States, Australia, Belgium, Germany, South Africa, Canada, Brazil, Czech Republic, Hungary
-
Bristol-Myers SquibbOno Pharma USA IncCompleted
-
AstraZenecaBristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted
-
National Cancer Institute (NCI)WithdrawnStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Stage IV Non-Small Cell Lung Cancer | Metastatic Pancreatic Adenocarcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast... and other conditions
-
Dana-Farber Cancer InstituteBristol-Myers SquibbRecruitingMeningiomasUnited States
-
The Netherlands Cancer InstituteBristol-Myers SquibbRecruitingColon CarcinomaNetherlands
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Recurrent Childhood Pilocytic Astrocytoma | Recurrent Childhood Visual Pathway GliomaUnited States, Canada, Australia, New Zealand
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Bristol-Myers SquibbActive, not recruitingMetastatic Uveal Melanoma | Metastatic Malignant Neoplasm in the Liver | Stage IV Uveal Melanoma AJCC v7United States
-
CSL BehringCompletedRheumatoid ArthritisItaly, Japan, Taiwan, United States, Spain, Argentina, Belgium, Germany, Korea, Republic of, Czechia, Russian Federation, France, Mexico, Poland, South Africa, Hungary, Brazil, Canada, Netherlands
-
Jonsson Comprehensive Cancer CenterGlaxoSmithKline; Novartis; Astellas Pharma Inc; Prostate Cancer Foundation; Medivation...Active, not recruitingProstate CancerUnited States
-
Bristol-Myers SquibbCompletedDepressionFrance, Sweden, United States, South Africa, Canada, Finland
-
Bristol-Myers SquibbCompletedHepatitis C VirusFrance, Germany, Korea, Republic of, Spain, Taiwan, United States, Canada, Australia, Russian Federation, Austria, Israel, Italy, Netherlands, Argentina, Poland, United Kingdom, Ireland, New Zealand
-
National Cancer Institute (NCI)Active, not recruitingAdult Solid NeoplasmUnited States
-
Bristol-Myers SquibbTerminatedAdvanced CancerChile, United States, Argentina, Australia, Belgium, Canada, Finland, France, Germany, Israel, Italy, Netherlands, Norway, Poland, Romania, Spain, Switzerland
-
Bristol-Myers SquibbCompletedSmall Cell Lung CancerUnited States, Belgium, Canada, Puerto Rico, Australia, Korea, Republic of, Netherlands
-
Robert L. Ferris, MD, PhDBristol-Myers SquibbActive, not recruitingOropharynx Squamous Cell Carcinoma | Carcinoma, Squamous Cell of Head and NeckUnited States
-
Bristol-Myers SquibbCompletedAdvanced or Metastatic MelanomaUnited States
-
Bristol-Myers SquibbMedarexCompletedMelanomaUnited States, Spain, Austria, Italy, Sweden, Russian Federation, Ukraine, Finland, Norway, Poland
-
Bristol-Myers SquibbCompletedBreast CancerUnited States, Peru, Argentina, Mexico
-
National Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid NeoplasmUnited States
-
Bristol-Myers SquibbCompletedDepressionItaly, South Africa, United States, Australia, Argentina, Canada, Austria, France, Spain, India, Puerto Rico, United Kingdom
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
AstraZenecaBristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedLocally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal JunctionFrance, Poland, Russian Federation, Taiwan, United States, Hong Kong, Spain, Germany, Italy, Japan, Korea, Republic of, Singapore
-
Georgetown UniversityBristol-Myers Squibb; Targovax ASA; Janssen, LPRecruitingPancreatic Ductal Adenocarcinoma | Refractory Non-Small Cell Lung CancerUnited States
-
Bristol-Myers SquibbRecruitingMelanomaUnited States, Canada, Switzerland, Italy, Spain, Australia, France, Belgium, Finland, Israel, Germany, Sweden, Argentina, Brazil, Colombia, Mexico, Norway, Chile, United Kingdom, Austria, Poland, Czechia
-
Bristol-Myers SquibbRecruiting
-
Calithera Biosciences, IncTerminatedMelanoma | Non-small Cell Lung Cancer (NSCLC) | Clear Cell Renal Cell Carcinoma (ccRCC)United States
-
Clovis Oncology, Inc.Bristol-Myers Squibb; European Network of Gynaecological Oncological Trial...SuspendedGynecologic Cancer | Advanced Solid TumorUnited States, Belgium, Spain, Germany, Austria, Italy
-
Emory UniversityBristol-Myers SquibbWithdrawnRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusUnited States, Canada, Mexico, India, Puerto Rico, Russian Federation, South Africa